UPC: 643950248476
| Skin Type | Flaky, itchy, sensitive, Sensitive, scalp, face & body |
| Product Benefits | Anti-Inflammatory, Hydrating, Nourishing, Seborrheic Dermatitis Relief, Soothing |
| Use for | Face, Whole Body |
| Scent | Tea Tree and Rosemary, natural fragrance from the essential oils, synthetic fragrance free |
| Special Ingredients | Aloe, Vitamin B3 Niacinamide, Water, Sodium Chloride (Sea Salt), Xylitol, Methylsulfonylmethane (MSM), Urea, Niacinamide, Colloidal Silver, Sodium Hyaluronate, Aloe Barbadensis Leaf Juice, Citrus Grandis (Grapefruit) Seed Extract, Melaleuca Alternifolia (Tea Tree) Leaf Oil, Rosemary (Rosmarinus Officinalis) Leaf Oil, Limonene* *natural allergen from essential oils”Aloe, Vitamin B3 Niacinamide, Water, Sodium Chloride (Sea Salt), Xylitol, Methylsulfonylmethane (MSM), Urea, Niacinamide, Colloidal Silver, Sodium Hyaluronate, Aloe Barbadensis Leaf Juice, Citrus Grandis (Grapefruit) Seed Extract, Melaleuca Alternifolia (Tea Tree) Leaf Oil, Rosemary (Rosmarinus Officinalis) Leaf Oil, Limonene* *natural allergen from essential oils” |
About this item
- VISIBLY REDUCES FLAKING & SOOTHES ITCH – For seborrheic dermatitis-prone, flaky, itchy skin. Helps calm visible redness and irritation across scalp, face, and body. Individual results may vary.
- STEROID-FREE & MALASSEZIA-SAFE – No steroids, sulfates, parabens, or triggering oils. Gentle enough for daily long-term use on reactive, imbalance-prone skin. Safe for color-treated hair.
- CLINICALLY STUDIED FORMULA – 92% of participants reported a calmer, flake-free scalp in a 3rd-party clinical trial. Key ingredients: Dead Sea Salt, Niacinamide, Hyaluronic Acid & MSM.
- WORKS ON SCALP, FACE & BODY – One serum for every problem area: scalp, hairline, ears, eyebrows, beard, and body. Apply overnight or as a leave-in for deep, lasting relief.
- DERMATOLOGIST TESTED – Pairs with Dermazen Scalp Therapy Shampoo, Nourishing Conditioner & Soothing Malassezia Moisturizer. Developed for long-term, steroid-free skin care.
Reviews
There are no reviews yet.